Zobrazeno 1 - 10
of 1 952
pro vyhledávání: '"Powderly J"'
Autor:
Lakhani, N., Cosman, R., Banerji, U., Rasco, D., Tomaszewska-Kiecana, M., Garralda, E., Kornacki, D., Li, J., Tian, C., Bourayou, N., Powderly, J.
Publikováno v:
In ESMO Open April 2024 9(4)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Taylor MH; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA xiaomin.schebye@immuneonc.com matthew.taylor@providence.org., Naing A; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Powderly J; Carolina BioOncology Institute, Huntersville, North Carolina, USA., Woodard P; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA., Chung L; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA., Lin WH; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA., Tian H; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA., Siemers N; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA., Xiang H; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA., Deng R; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA., Hong K; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA., Valencia D; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA., Huang T; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA., Zhu Y; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA., Liao XC; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA., Schebye XM; Immune-Onc Therapeutics, Inc, Palo Alto, California, USA xiaomin.schebye@immuneonc.com matthew.taylor@providence.org., Patel MR; Florida Cancer Specialists/ Sarah Cannon Research Institute, Sarasota, Florida, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Nov 20; Vol. 12 (11). Date of Electronic Publication: 2024 Nov 20.
Autor:
Shimizu T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of New Experimental Therapeutics and International Cancer New Drug Development Center, Kansai Medical University Hospital, Osaka, Japan., Powderly J; Carolina BioOncology Institute, Huntersville, NC, United States., Abdul Razak A; Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre, Toronto, ON, Canada., LoRusso P; Yale Cancer Center, Yale University, New Haven, CT, United States., Miller KD; Department of Medicine, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN, United States., Kao S; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, NSW, Australia., Kongpachith S; AbbVie Bay Area, South San Francisco, CA, United States., Tribouley C; AbbVie Bay Area, South San Francisco, CA, United States., Graham M; AbbVie Bay Area, South San Francisco, CA, United States., Stoll B; AbbVie Bay Area, South San Francisco, CA, United States., Patel M; AbbVie Bay Area, South San Francisco, CA, United States., Sahtout M; AbbVie Bay Area, South San Francisco, CA, United States., Blaney M; AbbVie Bay Area, South San Francisco, CA, United States., Leibman R; AbbVie Bay Area, South San Francisco, CA, United States., Golan T; Institute of Oncology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.; Oncology Institute, Sheba Medical Center at Tel-Hashomer, Tel Aviv University, Tel Aviv, Israel., Tolcher A; New Experimental Therapeutics (NEXT) Oncology, San Antonio, TX, United States.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 Oct 29; Vol. 14, pp. 1376551. Date of Electronic Publication: 2024 Oct 29 (Print Publication: 2024).
Autor:
Colevas, A.D. *, Bahleda, R., Braiteh, F., Balmanoukian, A., Brana, I., Chau, N.G., Sarkar, I., Molinero, L., Grossman, W. *, Kabbinavar, F., Fassò, M., O’Hear, C., Powderly, J.
Publikováno v:
In Annals of Oncology November 2018 29(11):2247-2253
Autor:
Davar, D., Knecht, J.G., Vandross, A.L., Perez, C.A., Miller, D.M., Powderly, J., Bessudo, A., Montazeri, K., Mooradian, M.J., Gupta, A., Patel, E., Fantini, D., Paramasivan, S., Crowe, D., Duncan, M., Uptain, S., Luptakova, K., Sullivan, R.
Publikováno v:
In Immuno-Oncology and Technology December 2023 20 Supplement
Autor:
Csiki, I., Glenn, J., Boccia, R., Chen, C., Gordon, M., Misleh, J., Powderly, J., Wainberg, Z.A., Spira, A., Klumpp, K.
Publikováno v:
In Immuno-Oncology and Technology December 2022 16 Supplement 1
Autor:
Imbimbo, M., Hollebecque, A., Italiano, A., McKean, M., Macarulla, T., Castanon Alvarez, E., Carneiro, B.A., Mager, R., Barnhart, V., Murtomaki, E., He, Y., Cooper, Z.A., Tu, E., Linke, A., Fan, C., Zhou, D., Boyer Chammard, A., Paturel, C.L., Fraenkel, P.G., Powderly, J.
Publikováno v:
In Immuno-Oncology and Technology December 2022 16 Supplement 1
Autor:
Papadopoulos, K., Li, T., Lakhani, N., Powderly, J., George, T., Teoh, D.G.K., Kilari, D., Giaccone, G., Sanborn, R.E., Ghamande, S., LoRusso, P., Gibney, G., Ma, V.T-L., Yalamanchili, K., Brown, J., Mota, N., Tasillo Kadra, C., Umiker, B., Xiao, X., Trehu, E.
Publikováno v:
In Immuno-Oncology and Technology December 2022 16 Supplement 1
Autor:
Gubens, M., Sen, S., Salkeni, M.A., Vandross, A., Gandhi, N., Edenfield, W.J., Aggarwal, R., Parsons, K., Chen, I., Powderly, J.
Publikováno v:
In Journal of Thoracic Oncology October 2024 19(10) Supplement:S243-S244